(Press-News.org) The Korea Electrotechnology Research Institute (KERI, President Kim Nam-Kyun), an internationally accredited testing and certification body for electrical equipment, has been accredited as a Type A Inspection Body by ACCREDIA, an international accreditation body in Italy.
An Inspection Body verifies the performance and quality of products, and an Accreditation Body attests and supervises Inspection Bodies to ensure their competence and impartiality.
ACCREDIA is a world leader in accreditation for electrical equipment. It is a full member of the International Accreditation Forum (IAF), the European co-operation for Accreditation (EA), and the International Laboratory Accreditation Co-operation (ILAC) with which it signed Mutual Recognition Agreements (MRAs). Countries and institutions that are parties to these MRAs recognize each other's test/inspection reports and certificates and accept them unconditionally.
KERI was already qualified to issue internationally recognized product certificates from ACCREDIA in 2003. In the past 20 years, KERI has contributed to the competitiveness of domestic power equipment manufacturers in the export market by helping them significantly reduce the time and costs of working through product certification process with overseas bodies.
Recently, however, the specifications of devices and products are increasingly complex, and many countries require specific versions of certificates depending on their national circumstance. In response, KERI sought to acquire the qualification to issue Certificates of Inspection in addition to existing Product Certificates, and KERI recently passed ACCREDIA’s strict assessment process to be accredited as an Inspection Body. KERI could offers various types of certificates to domestic manufacturers looking to overseas markets.
KERI is qualified to inspect products in six areas including high-voltage switchgear and controlgear and has the authority to issue internationally recognized Certificates of Inspection for 73 standards including IEC 62271-100. The Certificates of Inspection issued by KERI carry the ACCREDIA logo and are mutually recognized and accepted in 82 countries.
"As an ACCREDIA-accredited Inspection Body, our Certificates of Inspection have the same effect as those issued by overseas accredited Inspection Bodies and are accepted internationally," said Kim Nam-Kyun, KERI’s President. "We will strive to improve the international recognition and reliability of our certificates and test reports, thereby helping domestic electrical equipment companies develop export markets.”
Meanwhile, KERI plan to exhibit at 'Electric Energy Show 2023 In Hanoi' held in Hanoi, Vietnam (May 17 - May 19) as part of its endeavors to promote the testing/certification/inspection business. Now KERI aims to further strengthen the international acceptance and credential of its test reports and inspection certificates. <KERI>
[Glossary of Terms]
- Testing: The act of testing products/materials, etc., in accordance with standards, laws, regulations, etc., and providing results.
- Inspection: The act of inspecting products/materials in accordance with standards or laws and regulations, calculating the results, and determining and informing of whether the product/material is qualifiable.
- Certification: A written guarantee by a third party (certification body) that a product, service, or process conforms to the prescribed requirements according to formal procedures.
- Accreditation: Official recognition by an authorized accreditation body of an organization for its ability to perform certain tasks (calibration, testing, inspection, etc.) in accordance with the international standards set by law or a relevant international standards organization.
END
KERI accredited as an inspection body by ACCREDIA for electrical equipment
KERI set to support domestic manufacturers’ exports with globally accepted Certificates of Inspection for electrical equipment
2023-04-17
ELSE PRESS RELEASES FROM THIS DATE:
NCCS research luminaries conferred distinguished professorships in pathology and colorectal surgery
2023-04-17
Singapore, 16 April 2023 – The SingHealth Duke-NUS Academic Medical Centre (AMC) announced that Distinguished Professorships have been awarded to two research luminaries from the National Cancer Centre Singapore (NCCS). The Professorships are the highest honour bestowed upon faculty members by the SingHealth Duke-NUS AMC.
Professor Teh Bin Tean, Deputy Chief Executive Officer (Research), NCCS, and Professor, Duke-NUS Medical School, was conferred the Tan Yew Oo Professorship in Pathology and Associate Professor Iain Tan Bee Huat, Division Director of Research and Senior Consultant, Division of Medical Oncology, ...
Lower risk of severe illness and death in newborns of low-income immigrant than Canadian-born females
2023-04-17
Newborns of non-refugee immigrant females are at overall lower risk of serious illness and death than those of Canadian-born females in low-income neighbourhoods in Ontario, according to new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221711.
Previous research has looked at the risk of adverse outcomes for newborns in low- v. high-income neighbourhoods, but there is little evidence on the respective risks for immigrant and nonimmigrant mothers living in similar low-income neighbourhoods. Both immigration status and living in a low-income ...
Income rank linked to experience of physical pain, irrespective of whether in a rich or poor country, study suggests
2023-04-17
A new study of worldwide polling data suggests that a person’s income rank relative to their peers is linked to their experience of physical pain, with a lower income rank linked to a higher likelihood of experiencing pain. It is the first time such a relationship has been shown.
The study found the link to persist, to the same degree, irrespective of whether the person lives in a rich country or a poor country.
Income rank is the position of an individual’s absolute personal income amount in a list of those amounts ordered from lowest to highest. The higher the position in the list, the higher the income ...
Treatment with immunotherapy alone produces ‘exceptional’ response rates in some melanoma patients
2023-04-16
COLUMBUS, Ohio – Data from a national clinical trial shows that a striking 89% of patients with desmoplastic melanoma responded to immunotherapy (pembrolizumab) alone, suggesting that many patients could avoid the risk for toxicity from combination therapies and achieve cancer control with this approach to treatment.
Desmoplastic melanoma is a subset of melanoma skin cancer that is caused by high levels of ultraviolet (UV) radiation damage and, therefore, a high number of tumor mutations that all contribute to aggressive ...
SWOG S1512 trial sees high response rate to pembrolizumab in patients with unresectable desmoplastic melanoma
2023-04-16
Close to 90 percent of patients with unresectable (inoperable) desmoplastic melanoma, a rare form of skin cancer, saw their cancer improve after treatment with the immunotherapy drug pembrolizumab in a recent clinical trial.
These results from the S1512 trial conducted by the SWOG Cancer Research Network, a group funded by the National Cancer Institute (NCI), are being delivered in an oral presentation at the clinical trials plenary session of the 2023 annual meeting of the American Association for Cancer Research (AACR) in Orlando, Florida, on April 16th.
The S1512 ...
AACR: YAP/TEAD inhibitor VT3989 is well tolerated and shows antitumor activity in advanced mesothelioma and NF2-mutant cancers
2023-04-16
ABSTRACT: CT006
ORLANDO, Fla. ― The first-in-class YAP/TEAD inhibitor VT3989 was well tolerated with durable antitumor responses in patients with advanced malignant mesothelioma and other tumors with NF2 mutations, according to results of a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center. The first-in-human study was presented today at the American Association for Cancer Research (AACR) Annual Meeting 2023.
Seven of 69 patients had radiological partial responses that persisted up to at least 21 months, indicating tumor shrinkage, while 34 had stable disease. Patient benefit was observed in patients with both mesothelioma ...
AACR: Penn Medicine preclinical study identifies new target for recurrent ovarian cancer
2023-04-16
ORLANDO – Despite recent advances, ovarian cancer remains the fifth leading cause of cancer-related deaths among women, and there’s a critical need for new treatment options, especially for advanced cancers that grow back after standard of care treatment. Results from a preclinical study, led by researchers from the Perelman School of Medicine at the University of Pennsylvania, verified a new target for drug-resistant ovarian cancer and provided data to support a treatment approach that is already making its way into clinical trials.
Sarah Gitto, PhD, an instructor of Pathology and Laboratory ...
Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence
2023-04-16
VIDEO OF RESEARCHER AND PATIENT COMMENTARY IS AVAILABLE AT:
https://bcove.video/3mxxASq
The combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% when compared to immunotherapy alone, a new clinical trial shows.
Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the randomized phase 2b trial involved men and women who had surgery to remove melanoma from lymph nodes or other organs and were at high risk of the disease returning in sites distant from the original cancer. ...
AACR: Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery
2023-04-16
ABSTRACT: CT005
ORLANDO, Fla. ― A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to Phase III trial results presented today by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2023.
The ...
A new breakthrough in Alzheimer disease research - visualizing reactive astrocyte-neuron interaction
2023-04-16
Recently, a team of South Korean scientists led by Director C. Justin LEE of the Center for Cognition and Sociality within the Institute for Basic Science made a new discovery that can revolutionize both the diagnosis and treatment of Alzheimer’s Disease. The group demonstrated a mechanism where the astrocytes in the brain uptake elevated levels of acetates, which turns them into hazardous reactive astrocytes. They then went on further to develop a new imaging technique that takes advantage of this mechanism to directly observe the astrocyte-neuron interactions.
Alzheimer’s disease (AD), one of ...
LAST 30 PRESS RELEASES:
Stand up to cancer adds new expertise to scientific advisory committee
‘You don’t just throw them in a box.’ Archaeologists, Indigenous scholars call on museums to better care for animal remains
Can AI tell us if those Zoom calls are flowing smoothly? New study gives a thumbs up
The Mount Sinai Hospital ranked among world’s best in Newsweek/Statista rankings
Research shows humans have a long way to go in understanding a dog’s emotions
Discovery: The great whale pee funnel
Team of computer engineers develops AI tool to make genetic research more comprehensive
Are volcanoes behind the oxygen we breathe?
The two faces of liquid water
The Biodiversity Data Journal launches its own data portal on GBIF
Do firefighters face a higher brain cancer risk associated with gene mutations caused by chemical exposure?
Less than half of parents think they have accurate information about bird flu
Common approaches for assessing business impact on biodiversity are powerful, but often insufficient for strategy design
Can a joke make science more trustworthy?
Hiring strategies
Growing consumption of the American eel may lead to it being critically endangered like its European counterpart
KIST develops high-performance sensor based on two-dimensional semiconductor
New study links sleep debt and night shifts to increased infection risk among nurses
Megalodon’s body size and form uncover why certain aquatic vertebrates can achieve gigantism
A longer, sleeker super predator: Megalodon’s true form
Walking, moving more may lower risk of cardiovascular death for women with cancer history
Intracortical neural interfaces: Advancing technologies for freely moving animals
Post-LLM era: New horizons for AI with knowledge, collaboration, and co-evolution
“Sloshing” from celestial collisions solves mystery of how galactic clusters stay hot
Children poisoned by the synthetic opioid, fentanyl, has risen in the U.S. – eight years of national data shows
USC researchers observe mice may have a form of first aid
VUMC to develop AI technology for therapeutic antibody discovery
Unlocking the hidden proteome: The role of coding circular RNA in cancer
Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC
Study reveals widening heart disease disparities in the US
[Press-News.org] KERI accredited as an inspection body by ACCREDIA for electrical equipmentKERI set to support domestic manufacturers’ exports with globally accepted Certificates of Inspection for electrical equipment